课题基金 / 基金详情

Eicosanoid Balance in Lung Transplant Injury and Repair

Eicosanoid Balance in Lung Transplant Injury and Repair
肺移植损伤和修复中的类二十烷酸平衡
批准号:
7477823
负责人:
David J. Pinsky
金额:
$35.94万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2010-07-31
关键词:
AcuteAcute Lung InjuryAcute respiratory failureAgonistAirAnimal ModelArachidonate 5-LipoxygenaseBiological PreservationBleomycinBlood VesselsBlood flowBreathingBronchiolitis ObliteransBronchitisCause of DeathCellsChronicCyclic AMPCyclic AMP-Dependent Protein KinasesDataDevelopmentDinoprostoneEdemaEicosanoid ProductionEicosanoidsEnd PointEnzymesEpithelialEpoprostenolEquilibriumFamilyFibrosisFlushingG-Protein-Coupled ReceptorsGenesGeneticGrantHomeostasisIloprostImmune responseIn VitroInfectionInflammationInflammatoryInjuryIschemiaKnockout MiceLaboratoriesLeukocyte TraffickingLeukotriene B4LeukotrienesLipoxygenase InhibitorsLiquid substanceLungLung TransplantationLymphocyteMeasuresMediatingMediator of activation proteinModelingMorbidity - disease rateMusMyofibroblastObstructionOrganOutcomePathway interactionsPatientsPhysiologicalPhysiological reperfusionProceduresProductionProstaglandin ProductionProstaglandin ReceptorProstaglandin-Endoperoxide SynthaseProstaglandinsProstaglandins EProstaglandins IProtein KinasePublic HealthPulmonary Gas ExchangeRattusReceptor SignalingReperfusion InjuryReperfusion TherapyResearch PersonnelRespiratory physiologyRodent ModelRoleSeriesSignal PathwaySignal TransductionSolutionsTestingTherapeuticThrombosisTimeTranslatingTransplantationViralanalogcell injurycyclooxygenase 1cyclooxygenase 2cysteinyl-leukotrienecytokineenzyme biosynthesisgraft failureimprovedinhibitor/antagonistinjuredinjured airwayinjury and repairlipid mediatorlung injurylung ischemialung preservationmortalitymouse modelnovel therapeuticsprogramsprostaglandin EP2 receptorreceptorresearch studyresponseresponse to injurysynthetic enzymetoolvasoconstriction

项目摘要

项目成果

David J. Pinsky的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Lung transplantation (LTX) reduces morbidity and mortality from respiratory failure, but acute and long-term outcomes remain poor. Primary lung graft failure occurs in up to 20% of recipients, and by 5 years, over half of all patients develop bronchiolitis obliterans (BO), the major cause of death outside of infections. This project focuses on the balance between two countervailing eicosanoid pathways of cellular injury and repair in the lungs, prostaglandins (PGs) and leukotrienes (LTs), in acute and chronic lung injury associated with transplantation. Preliminary data show PGE^ added to the lung flush/preservation solution reduces ischemia/reperfusion (I/R) injury (a known contributor to BO), by stimulating the cAMP-dependent protein kinase. Using an air-flow permissive airway transplant model that we developed, mice deficient in the 5- lipoxygenase (5-LO) gene, responsible for the initial step in LT synthesis, appear to be protected from BO. In vitro supporting data suggest that in lung-derived myofibroblasts, LTs promote but PGs suppress inflammatory mediator synthesis and fibrosis. We hypothesize that eicosanoids modulate both the acute and chronic host responses to LTX injury, with PGs preserving vascular homeostasis and limiting airway obliteration but LTs having the opposite effect. The Specific Aims are to determine the role of (1) endogenous PGs and (2) LTs and their synthetic enzymes and signaling receptors in the response of the lungs to ischemic/transplantation injury, using rodent models of lung I/R, LTX, and airway transplantation. Aim (3) will determine the role of eicosanoid balance in BO development following second hit (ischemic, viral) injury, use genetic (COX, prostanoid receptor [EP2], and 5-LO deficient) and pharmacologic (COX and 5-LO inhibitor, LT receptor antagonist) strategies. Inhalation of PGs will be studied as a potential new therapeutic strategy to reduce primary graft failure and BO. Taken together, these experiments will elucidate the role of the prevailing eicosanoid balance as a critical facet of the host response to LTX. Public Health Implications: Certain native substances made by cells in the lungs can injure blood vessels and airways in transplanted lungs, leading to their obstruction, whereas other related substances are protective. This grant seeks to understand the balance between these injurious and protective substances, to develop strategies which may tip the balance in favor of protecting transplanted lungs from lethal injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Purinergic regulation of Innate Immunity to promote Venous Homeostasis
Purinergic regulation of Innate Immunity to promote Venous Homeostasis
Thrombo-Inflammatory Role of CD39 In Vascular Stasis
Thrombotic/Fibrinolytic Balance in Cardiac Transplant Vasculopathy
海外基金